PHIDELTA PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHIDELTA PHARMA
Largest movements
- Intangible fixed assets -€22,500
down €22,500 (-28.6%), from €78,750 to €56,250
- Receivables within one year +€16,350
up €16,350 (+29.5%), from €55,369 to €71,719
of which Trade receivables: +€18,627
- Tangible fixed assets -€3,759
down €3,759 (-33.4%), from €11,261 to €7,502
of which Other tangible fixed assets: -€2,727
- Other debts -€26,169
down €26,169 (-29.2%), from €89,523 to €63,354
- Trade debts +€23,640
up €23,640 (+45.7%), from €51,741 to €75,381
- Tax, wage and social debts -€5,148
down €5,148 (-17.9%), from €28,726 to €23,579
of which Taxes: -€5,881
- Gross operating margin -€8,450
down €8,450 (-6.6%), from €128,180 to €119,730
- Staff costs -€3,957
down €3,957 (-4.2%), from €95,012 to €91,055
- Financial charges -€2,588
down €2,588 (-61.7%), from €4,192 to €1,604
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €226,312 | €216,336 | -€9,976 | -4.4% |
| Fixed assets | 21/28 | €90,011 | €63,752 | -€26,259 | -29.2% |
| Intangible fixed assets | 21 | €78,750 | €56,250 | -€22,500 | -28.6% |
| Tangible fixed assets | 22/27 | €11,261 | €7,502 | -€3,759 | -33.4% |
| Plant, machinery and equipment | 23 | €1,279 | €684 | -€595 | -46.5% |
| Furniture and vehicles | 24 | €438 | - | -€438 | |
| Other tangible fixed assets | 26 | €9,544 | €6,817 | -€2,727 | -28.6% |
| Current assets | 29/58 | €136,301 | €152,584 | +€16,283 | +11.9% |
| Stocks and contracts in progress | 3 | €46,480 | €48,054 | +€1,574 | +3.4% |
| Stocks | 30/36 | €46,480 | €48,054 | +€1,574 | +3.4% |
| Amounts receivable within one year | 40/41 | €55,369 | €71,719 | +€16,350 | +29.5% |
| Trade receivables | 40 | €47,728 | €66,356 | +€18,627 | +39.0% |
| Other amounts receivable | 41 | €7,641 | €5,363 | -€2,277 | -29.8% |
| Cash at bank and in hand | 54/58 | €33,233 | €31,342 | -€1,891 | -5.7% |
| Deferred charges and accrued income | 490/1 | €1,219 | €1,469 | +€250 | +20.5% |
| Total equity and liabilities | 10/49 | €226,312 | €216,336 | -€9,976 | -4.4% |
| Equity | 10/15 | €53,905 | €53,943 | +€38 | +0.1% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €41,000 | €41,000 | = | 0.0% |
| Distributable reserves | 133 | €41,000 | €41,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €505 | €543 | +€38 | +7.6% |
| Amounts payable | 17/49 | €172,407 | €162,393 | -€10,014 | -5.8% |
| Amounts payable within one year | 42/48 | €170,583 | €162,313 | -€8,270 | -4.8% |
| Current portion of amounts payable after more than one year | 42 | €593 | - | -€593 | |
| Trade debts | 44 | €51,741 | €75,381 | +€23,640 | +45.7% |
| Suppliers | 440/4 | €51,741 | €75,381 | +€23,640 | +45.7% |
| Taxes, remuneration and social security | 45 | €28,726 | €23,579 | -€5,148 | -17.9% |
| Taxes | 450/3 | €8,889 | €3,008 | -€5,881 | -66.2% |
| Remuneration and social security | 454/9 | €19,837 | €20,571 | +€733 | +3.7% |
| Other amounts payable | 47/48 | €89,523 | €63,354 | -€26,169 | -29.2% |
| Accrued charges and deferred income | 492/3 | €1,824 | €80 | -€1,744 | -95.6% |
| Remuneration, social security and pensions | 62 | €95,012 | €91,055 | -€3,957 | -4.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €27,248 | €26,259 | -€989 | -3.6% |
| Other operating charges | 640/8 | €650 | €358 | -€292 | -44.9% |
| Gross operating margin | 9900 | €128,180 | €119,730 | -€8,450 | -6.6% |
| Operating profit (loss) | 9901 | €5,270 | €2,058 | -€3,212 | -60.9% |
| Financial income | 75/76B | €134 | €23 | -€111 | -83.2% |
| Recurring financial income | 75 | €134 | €23 | -€111 | -83.2% |
| Financial charges | 65/66B | €4,192 | €1,604 | -€2,588 | -61.7% |
| Recurring financial charges | 65 | €4,192 | €1,604 | -€2,588 | -61.7% |
| Profit (loss) for the period before taxes | 9903 | €1,211 | €476 | -€735 | -60.7% |
| Income taxes | 67/77 | €852 | €438 | -€414 | -48.6% |
| Profit (loss) for the period | 9904 | €359 | €38 | -€321 | -89.4% |
| Profit (loss) for the period to be appropriated | 9905 | €359 | €38 | -€321 | -89.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.